Last 47 quarters of trend data · Healthcare · Medical - Instruments & Supplies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 31.33 | 32.42 | 40.14 | 29.82 | 29.17 | 34.60 | 43.70 | 47.01 | 47.39 | 39.56 | 38.58 | 37.34 | 41.27 | 46.72 | 47.66 | 46.02 | 50.68 | 71.17 | 43.03 | 44.85 | 44.24 |
| — | -6.3% | -8.2% | -36.6% | -38.5% | -12.5% | +13.3% | +25.9% | +14.8% | -15.3% | -19.0% | -18.9% | -18.6% | -34.4% | +10.8% | +2.6% | +14.6% | +86.6% | -1.2% | +50.6% | +101.3% | |
| P/S Ratio | 7.23 | 8.36 | 9.44 | 7.23 | 8.74 | 7.40 | 8.02 | 9.47 | 9.67 | 8.37 | 7.05 | 6.52 | 6.46 | 7.54 | 6.09 | 6.25 | 7.21 | 5.98 | 6.49 | 7.04 | 7.59 |
| — | +13.0% | +17.7% | -23.7% | -9.6% | -11.6% | +13.8% | +45.2% | +49.8% | +11.1% | +15.8% | +4.4% | -10.5% | +25.9% | -6.2% | -11.2% | -4.9% | -23.9% | -8.4% | +26.6% | +66.0% | |
| P/B Ratio | 4.60 | 5.60 | 6.18 | 4.73 | 5.63 | 5.24 | 5.53 | 6.26 | 6.41 | 5.85 | 4.89 | 4.28 | 4.24 | 5.32 | 4.18 | 3.82 | 4.31 | 3.91 | 3.98 | 4.38 | 4.68 |
| — | +6.8% | +11.9% | -24.3% | -12.1% | -10.4% | +13.1% | +46.2% | +51.0% | +10.0% | +16.9% | +12.1% | -1.5% | +36.2% | +4.9% | -12.8% | -7.8% | -43.2% | -30.4% | -9.6% | +13.0% | |
| P/FCF | 24.23 | 43.11 | 51.06 | 21.78 | 20.15 | 25.08 | 62.74 | 40.15 | 42.17 | 60.34 | 101.87 | 33.66 | 28.43 | 41.50 | 1923.56 | 90.82 | 40.90 | 30.45 | 61.50 | 62.47 | 23.74 |
| — | +71.9% | -18.6% | -45.8% | -52.2% | -58.4% | -38.4% | +19.3% | +48.3% | +45.4% | -94.7% | -62.9% | -30.5% | +36.3% | +3027.5% | +45.4% | +72.3% | -19.1% | +21.3% | +287.1% | +92.8% | |
| EV / EBITDA | 25.04 | 24.09 | 32.81 | 23.56 | 25.02 | 27.41 | 34.28 | 37.02 | 34.01 | 27.83 | 26.31 | 25.09 | 26.43 | 32.01 | 28.03 | 27.58 | 33.20 | 30.52 | 24.93 | 24.90 | 24.25 |
| — | -12.1% | -4.3% | -36.4% | -26.4% | -1.5% | +30.3% | +47.5% | +28.7% | -13.1% | -6.1% | -9.0% | -20.4% | +4.9% | +12.4% | +10.7% | +36.9% | +31.6% | +1.3% | +39.4% | +72.7% | |
| EV / EBIT | 28.89 | 36.37 | 31.91 | 23.38 | 24.03 | 26.59 | 33.50 | 32.11 | 36.40 | 30.08 | 29.31 | 25.42 | 33.32 | 39.14 | 35.04 | 32.73 | 45.76 | 28.24 | 32.39 | 33.04 | 32.13 |
| — | +36.8% | -4.7% | -27.2% | -34.0% | -11.6% | +14.3% | +26.3% | +9.2% | -23.1% | -16.3% | -22.3% | -27.2% | +38.6% | +8.2% | -0.9% | +42.4% | -4.6% | +0.5% | +45.6% | +81.0% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.5% | 72.1% | 72.7% | 71.7% | 75.3% | 70.0% | 69.2% | 69.3% | 67.8% | 68.9% | 68.6% | 68.1% | 65.0% | 64.0% | 65.6% | 63.6% | 64.2% | 66.0% | 65.6% | 65.7% | 64.8% |
| — | +3.0% | +5.1% | +3.5% | +11.0% | +1.7% | +0.9% | +1.8% | +4.3% | +7.6% | +4.5% | +7.0% | +1.2% | -3.1% | -0.0% | -3.2% | -0.9% | +0.4% | -1.1% | +1.1% | +4.0% | |
| Operating Margin | 27.2% | 29.0% | 26.7% | 29.2% | 33.3% | 25.1% | 21.1% | 23.1% | 24.0% | 25.7% | 22.2% | 20.9% | 19.4% | 18.9% | 16.7% | 17.0% | 15.8% | 13.7% | 20.0% | 21.0% | 23.6% |
| — | +15.3% | +26.6% | +26.6% | +38.7% | -2.4% | -5.0% | +10.5% | +23.9% | +36.5% | +32.7% | +22.7% | +22.9% | +37.3% | -16.5% | -19.0% | -33.4% | -49.7% | -9.5% | -17.3% | -14.0% | |
| Net Margin | 23.1% | 24.2% | 23.6% | 24.2% | 28.4% | 21.5% | 18.4% | 20.1% | 20.3% | 21.2% | 18.5% | 17.3% | 15.8% | 16.2% | 12.8% | 13.7% | 14.0% | 8.3% | 15.3% | 15.6% | 17.0% |
| — | +12.9% | +28.1% | +20.4% | +39.9% | +1.3% | -0.5% | +15.9% | +28.4% | +31.0% | +44.1% | +26.0% | +13.2% | +93.6% | -15.9% | -12.1% | -17.5% | -59.1% | -7.6% | -16.5% | -17.8% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 15.8% | 4.1% | 3.9% | 4.0% | 4.7% | 3.9% | 3.2% | 3.3% | 3.4% | 3.8% | 3.3% | 2.9% | 2.6% | 2.9% | 2.2% | 2.1% | 2.1% | 1.4% | 2.4% | 2.5% | 3.0% |
| — | +6.3% | +21.9% | +20.6% | +36.7% | +3.0% | -1.4% | +15.9% | +30.7% | +29.7% | +46.4% | +35.8% | +24.7% | +113.0% | -5.6% | -13.4% | -29.7% | -70.2% | -30.4% | -41.8% | -37.6% | |
| ROA | 9.9% | 2.7% | 2.5% | 2.6% | 3.0% | 2.4% | 2.0% | 2.4% | 3.0% | 3.3% | 2.8% | 2.5% | 2.3% | 2.5% | 1.9% | 1.8% | 1.8% | 1.2% | 2.1% | 2.1% | 2.4% |
| — | +10.4% | +26.7% | +6.6% | -1.9% | -26.3% | -29.6% | -3.2% | +32.5% | +30.6% | +46.1% | +35.4% | +25.2% | +112.6% | -6.4% | -13.4% | -25.2% | -64.7% | -13.0% | -22.4% | -16.4% | |
| ROIC | 9.7% | 2.7% | 2.4% | 2.6% | 2.9% | 2.4% | 1.9% | 2.3% | 3.1% | 3.5% | 3.0% | 2.6% | 2.4% | 2.6% | 2.2% | 2.0% | 1.8% | 1.7% | 2.3% | 2.5% | 3.0% |
| — | +12.7% | +26.3% | +11.0% | -6.2% | -32.7% | -37.2% | -11.5% | +26.4% | +37.0% | +37.1% | +33.0% | +35.3% | +50.8% | -5.4% | -19.6% | -40.6% | -58.8% | -22.0% | -29.5% | -15.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.47 | 0.45 | 0.47 | 0.47 | 0.49 | 0.51 | 0.53 | 0.55 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | 0.06 | 0.06 | 0.07 |
| — | -11.7% | -12.5% | -14.3% | +785.0% | +789.6% | +771.3% | +758.9% | -5.4% | -2.7% | +1.7% | +3.6% | -8.6% | -11.2% | -0.4% | -1.3% | -3.3% | -68.6% | -77.4% | -80.2% | -86.1% | |
| Debt / EBITDA | 2.37 | 7.28 | 9.31 | 8.66 | 8.10 | 9.89 | 12.21 | 12.11 | 1.18 | 1.10 | 1.32 | 1.51 | 1.46 | 1.43 | 1.61 | 1.79 | 1.97 | 2.09 | 1.51 | 1.42 | 1.37 |
| — | -26.4% | -23.8% | -28.5% | +588.1% | +800.9% | +822.0% | +702.3% | -19.3% | -23.0% | -17.9% | -15.8% | -26.1% | -31.8% | +6.7% | +25.9% | +43.5% | -25.9% | -66.3% | -68.6% | -77.2% | |
| Current Ratio | 12.89 | 16.31 | 14.32 | 12.89 | 13.58 | 13.96 | 16.49 | 13.14 | 7.74 | 8.36 | 7.57 | 6.51 | 6.28 | 6.75 | 6.89 | 6.39 | 6.53 | 6.34 | 7.74 | 6.41 | 6.06 |
| — | +16.9% | -13.2% | -1.9% | +75.4% | +66.9% | +117.9% | +101.8% | +23.3% | +23.9% | +9.8% | +2.0% | -3.9% | +6.4% | -11.0% | -0.4% | +7.8% | +51.4% | +90.4% | +71.1% | +163.4% | |
| Quick Ratio | 10.95 | 13.96 | 12.20 | 10.95 | 11.45 | 12.09 | 14.23 | 11.31 | 5.79 | 6.14 | 5.54 | 4.76 | 4.51 | 4.85 | 4.85 | 4.60 | 4.72 | 4.56 | 5.48 | 4.55 | 4.31 |
| — | +15.4% | -14.3% | -3.2% | +97.6% | +97.1% | +157.0% | +137.6% | +28.5% | +26.5% | +14.2% | +3.6% | -4.5% | +6.4% | -11.5% | +1.1% | +9.7% | +92.5% | +137.6% | +107.6% | +205.1% | |
| Interest Coverage | 15.50 | 13.29 | 16.13 | 16.64 | 18.40 | 14.91 | 12.04 | — | — | — | — | — | — | — | — | — | — | — | — | 16.03 | 14.58 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying LMAT stock.
LeMaitre Vascular, Inc.'s current P/E is 31.3x. The average P/E over the last 4 quarters is 32.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
LeMaitre Vascular, Inc.'s current operating margin is 27.2%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking LeMaitre Vascular, Inc.'s business trajectory between earnings reports.